Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Collections
      • Disparities Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Collections
      • Disparities Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Research Articles

Aberrant Methylation of p16INK4a in Anatomic and Gender-specific Subtypes of Sporadic Colorectal Cancer

John K. Wiencke, Shichun Zheng, Amalia Lafuente, Maria Jose Lafuente, Corita Grudzen, Margaret R. Wrensch, Rei Miike, Antonio Ballesta and Manuel Trias
John K. Wiencke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shichun Zheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amalia Lafuente
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Jose Lafuente
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corita Grudzen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret R. Wrensch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rei Miike
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Ballesta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Trias
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published June 1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Colorectal cancer (CRC) occurring in the proximal colon and among women may represent a distinct subtype of the disease. In the present study of 120 sporadic CRCs, we used methylation-specific PCR to test whether methylation of the CpG island in the 5′ region of the p16INK4a tumor suppressor gene was associated with anatomical location, gender, or other clinicopathological characteristics. Overall, 18.3% of the tumors had detectable p16INK4a methylation. A marked preponderance of methylated tumors occurred within the proximal colon; cancers occurring proximal to the sigmoid colon were 13.1 times more likely to contain methylated p16INK4a compared with distal tumors. In addition, female patients were 8.8 times more likely than males to have methylation-positive cancers, and p16INK4a methylation was also associated with poorly differentiated tumors. The localization of tumors with p16INK4a methylation within the proximal colon and among female patients specifically adds to a growing database of molecular alterations that define important subtypes of sporadic CRC. The potentially reversible nature of CpG methylation may provide novel therapeutic opportunities for this increasing subtype of the disease, which, due to anatomical location, presents a great challenge for early detection.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • ↵1 Supported by the Foundation Marato (A. L., M. J. L.) and the National Institutes of Environmental Health Sciences NIH Grant P42-ESO4705 with funds provided by the Environmental Protection Agency (J. K. W., S. Z., C. G.).

  • ↵2 To whom requests for reprints should be addressed, at Laboratory for Molecular Epidemiology, Department of Epidemiology and Biostatistics, University of California San Francisco, 500 Parnassus Avenue, MU-W 420, San Francisco, CA 94143-0560.

  • ↵3 The abbreviations used are: CRC, colorectal cancer; MSPCR, methylation-specific PCR; APC, adenomatous polyposis coli; HNPCC, hereditary nonpolyposis colorectal cancer; OR, odds ratio.

    • Accepted April 7, 1999.
    • Received December 4, 1998.
    • Revision received March 15, 1999.
View Full Text
PreviousNext
Back to top
June 1999
Volume 8, Issue 6
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Aberrant Methylation of p16INK4a in Anatomic and Gender-specific Subtypes of Sporadic Colorectal Cancer
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
Citation Tools
Aberrant Methylation of p16INK4a in Anatomic and Gender-specific Subtypes of Sporadic Colorectal Cancer
John K. Wiencke, Shichun Zheng, Amalia Lafuente, Maria Jose Lafuente, Corita Grudzen, Margaret R. Wrensch, Rei Miike, Antonio Ballesta and Manuel Trias
Cancer Epidemiol Biomarkers Prev June 1 1999 (8) (6) 501-506;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Aberrant Methylation of p16INK4a in Anatomic and Gender-specific Subtypes of Sporadic Colorectal Cancer
John K. Wiencke, Shichun Zheng, Amalia Lafuente, Maria Jose Lafuente, Corita Grudzen, Margaret R. Wrensch, Rei Miike, Antonio Ballesta and Manuel Trias
Cancer Epidemiol Biomarkers Prev June 1 1999 (8) (6) 501-506;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Associations of Tobacco and Alcohol with SINT Risk in Utah
  • A Prognostic ATG-Based Scoring System in Ovarian Cancer
  • Antiparietal Cell Antibody and Esophageal and Gastric Cancer
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement